Survival rates for ALL have improved significantly over the past few decades, thanks to advances in treatment protocols. The 5-year survival rate for children can be as high as 90%, while for adults, it is lower, around 40%. Mortality rates are higher in older adults and those with poor prognostic factors such as high white blood cell count at diagnosis or certain genetic abnormalities.
